CD8A and neoplasm: Importantly, TAK-676 also exerted its effects within the tumor-draining lymph nodes, demonstrated by the increase in total viable cells, increased frequency of DCs, and increased activation and proliferation of CD8+ T cells over that of vehicle treated mice.